Literature DB >> 21957297

Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins.

Jiawen Wang1, Wenyan Zhang, Mingyu Lv, Tao Zuo, Wei Kong, Xianghui Yu.   

Abstract

Various feline APOBEC3 (fA3) proteins exhibit broad antiviral activities against a wide range of viruses, such as feline immunodeficiency virus (FIV), feline foamy virus (FFV), and feline leukemia virus (FeLV), as well as those of other species. This activity can be counteracted by the FIV Vif protein, but the mechanism by which FIV Vif suppresses fA3s is unknown. In the present study, we demonstrated that FIV Vif could act via a proteasome-dependent pathway to overcome fA3s. FIV Vif interacted with feline cellular proteins Cullin5 (Cul5), ElonginB, and ElonginC to form an E3 complex to induce degradation of fA3s. Both the dominant-negative Cul5 mutant and a C-terminal hydrophilic replacement ElonginC mutant potently disrupted the FIV Vif activity against fA3s. Furthermore, we identified a BC-box motif in FIV Vif that was essential for the recruitment of E3 ubiquitin ligase and also required for FIV Vif-mediated degradation of fA3s. Moreover, despite the lack of either a Cul5-box or a HCCH zinc-binding motif, FIV Vif specifically selected Cul5. Therefore, FIV Vif may interact with Cul5 via a novel mechanism. These finding imply that SOCS proteins may possess distinct mechanisms to bind Cul5 during formation of the Elongin-Cullin-SOCS box complex.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21957297      PMCID: PMC3209414          DOI: 10.1128/JVI.05218-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

2.  Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.

Authors:  Ying Dang; Roderick W Davis; Ian A York; Yong-Hui Zheng
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

3.  Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.

Authors:  Andrew Mehle; Joao Goncalves; Mariana Santa-Marta; Mark McPike; Dana Gabuzda
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

4.  Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids.

Authors:  Jörg Zielonka; Daniela Marino; Henning Hofmann; Naoya Yuhki; Martin Löchelt; Carsten Münk
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

5.  Repression of porcine endogenous retrovirus infection by human APOBEC3 proteins.

Authors:  Jungeun Lee; Jae Yoo Choi; Hee-Jung Lee; Kang-Chang Kim; Byeong-Sun Choi; Yu-Kyoung Oh; Young Bong Kim
Journal:  Biochem Biophys Res Commun       Date:  2011-03-23       Impact factor: 3.575

6.  The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex.

Authors:  Julien R C Bergeron; Hendrik Huthoff; Dennis A Veselkov; Rebecca L Beavil; Peter J Simpson; Stephen J Matthews; Michael H Malim; Mark R Sanderson
Journal:  PLoS Pathog       Date:  2010-06-03       Impact factor: 6.823

7.  A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.

Authors:  Gongying Chen; Zhiwen He; Tao Wang; Rongzhen Xu; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

8.  The sor gene of HIV-1 is required for efficient virus transmission in vitro.

Authors:  A G Fisher; B Ensoli; L Ivanoff; M Chamberlain; S Petteway; L Ratner; R C Gallo; F Wong-Staal
Journal:  Science       Date:  1987-08-21       Impact factor: 47.728

9.  APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells.

Authors:  Hal P Bogerd; Heather L Wiegand; Brian P Doehle; Kira K Lueders; Bryan R Cullen
Journal:  Nucleic Acids Res       Date:  2006-01-10       Impact factor: 16.971

Review 10.  HIV-1 Vif, APOBEC, and intrinsic immunity.

Authors:  Ritu Goila-Gaur; Klaus Strebel
Journal:  Retrovirology       Date:  2008-06-24       Impact factor: 4.602

View more
  22 in total

1.  Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.

Authors:  Qinyong Gu; Zeli Zhang; Lucía Cano Ortiz; Ana Cláudia Franco; Dieter Häussinger; Carsten Münk
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

Review 2.  The Road Less Traveled: HIV's Use of Alternative Routes through Cellular Pathways.

Authors:  Ailie Marx; Akram Alian
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

3.  Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.

Authors:  Tao Zuo; Donglai Liu; Wei Lv; Xiaodan Wang; Jiawen Wang; Mingyu Lv; Wenlin Huang; Jiaxin Wu; Haihong Zhang; Hongwei Jin; Liangren Zhang; Wei Kong; Xianghui Yu
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

4.  Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.

Authors:  Youwei Ai; Dantong Zhu; Cuihui Wang; Chao Su; Jian Ma; Jianzhang Ma; Xiaojun Wang
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

5.  Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.

Authors:  Qinyong Gu; Zeli Zhang; Christoph G W Gertzen; Dieter Häussinger; Holger Gohlke; Carsten Münk
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

6.  Vif determines the requirement for CBF-β in APOBEC3 degradation.

Authors:  Rokusuke Yoshikawa; Junko S Takeuchi; Eri Yamada; Yusuke Nakano; Fengrong Ren; Hiroshi Tanaka; Carsten Münk; Reuben S Harris; Takayuki Miyazawa; Yoshio Koyanagi; Kei Sato
Journal:  J Gen Virol       Date:  2014-12-16       Impact factor: 3.891

7.  Viral Restriction Activity of Feline BST2 Is Independent of Its N-Glycosylation and Induction of NF-κB Activation.

Authors:  Weiran Wang; Jiawen Wang; Meng Qu; Xiaojun Li; Jingyao Zhang; Haihong Zhang; Jiaxin Wu; Bin Yu; Hui Wu; Wei Kong; Xianghui Yu
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

Review 8.  Host restriction of lentiviruses and viral countermeasures: APOBEC3 and Vif.

Authors:  Stefán R Jónsson; Valgerdur Andrésdóttir
Journal:  Viruses       Date:  2013-07-30       Impact factor: 5.048

9.  Epitope tags beside the N-terminal cytoplasmic tail of human BST-2 alter its intracellular trafficking and HIV-1 restriction.

Authors:  Mingyu Lv; Jiawen Wang; Jingyao Zhang; Biao Zhang; Xiaodan Wang; Yingzi Zhu; Tao Zuo; Donglai Liu; Xiaojun Li; Jiaxin Wu; Haihong Zhang; Bin Yu; Hui Wu; Xinghong Zhao; Wei Kong; Xianghui Yu
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

10.  Role of cullin-elonginB-elonginC E3 complex in bovine immunodeficiency virus and maedi-visna virus Vif-mediated degradation of host A3Z2-Z3 proteins.

Authors:  Jingyao Zhang; Jiaxin Wu; Weiran Wang; Hui Wu; Bin Yu; Jiawen Wang; Mingyu Lv; Xiaodan Wang; Haihong Zhang; Wei Kong; Xianghui Yu
Journal:  Retrovirology       Date:  2014-09-12       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.